Stroke Risk in the Contemporary Era of Left Ventricular Assist Device Support
The HeartMate 3 left ventricular assist device (LVAD) has lower stroke rates compared to the HeartMate 2 in a clinical trial setting. Here we report real world stroke rates in patients implanted with HeartMate 2 and HeartMate 3 LVADs.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J. Leonard, A. Shaaban, A.C. Agdamag, Z. Jedeon, R. John, F. Kamdar, V. Maharaj, R. Cogswell Tags: (119) Source Type: research
More News: Cardiology | Clinical Trials | Heart | Heart Transplant | Lung Transplant | Stroke | Transplant Surgery | Transplants